COVID-19 is a rapidly growing pandemic with its first case identified during December 2019
in Wuhan, Hubei Province, China. Due to the rampant rise in the number of cases in China …

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) generated a
worldwide emergency, until the declaration of the pandemic in March 2020. SARS-CoV-2 …

The number of reported cases with coronavirus disease 2019 (COVID-19) has exceeded
620 million worldwide, still having a profound impact on people's health and daily lives since …

Importance SARS-CoV-2 viral entry may disrupt angiotensin II (AII) homeostasis,
contributing to COVID-19 induced lung injury. AII type 1 receptor blockade mitigates lung …

Background Endothelial dysfunction has been proposed to play a key role in the
pathogenesis of coronavirus disease 2019 (COVID-19) and its post-acute sequelae. Flow …

Background Renin‐angiotensin aldosterone system (RAAS) inhibitor—COVID‐19 studies,
observational in design, appear to use biased methods that can distort the interaction …

Background Over 130 million people have been diagnosed with Coronavirus disease 2019
(COVID-19), and more than one million fatalities have been reported worldwide. South …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or COVID-19 infection is
the cause of the ongoing global pandemic. Mortality from COVID-19 infection is particularly …

Despite the progressive improvements in diagnosis and therapy during the first 20 years of
this century, the morbidity and mortality of patients with heart failure (HF) remain high …

Among various factors influencing the course of SARS-CoV-2 infection in humans,
macrophage overactivation is considered the main cause of the cytokine storm that leads to …